Cargando…
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
Autores principales: | Sharun, Khan, Dhama, Kuldeep, Patel, Shailesh Kumar, Pathak, Mamta, Tiwari, Ruchi, Singh, Bhoj Raj, Sah, Ranjit, Bonilla-Aldana, D. Katterine, Rodriguez-Morales, Alfonso J., Leblebicioglu, Hakan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261036/ https://www.ncbi.nlm.nih.gov/pubmed/32473642 http://dx.doi.org/10.1186/s12941-020-00368-w |
Ejemplares similares
-
Global Threat of SARS-CoV-2/COVID-19 and the Need for More and Better Diagnostic Tools
por: Pathak, Mamta, et al.
Publicado: (2020) -
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
por: Dhama, Kuldeep, et al.
Publicado: (2020) -
COVID-19: animals, veterinary and zoonotic links
por: Tiwari, Ruchi, et al.
Publicado: (2020) -
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
por: Rabaan, Ali A., et al.
Publicado: (2020) -
SARS-CoV-2 jumping the species barrier: Zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus
por: Dhama, Kuldeep, et al.
Publicado: (2020)